Product logins

Find logins to all Clarivate products below.


General Radiography Systems | Medtech 360 | Market Analysis | Global | 2016

The ongoing global shift away from analog and CR systems toward DR systems will be the principal driver of growth in the general radiography system market through 2024, especially in China and Brazil where DR system penetration is low. Moreover, the digitization of health care facilities and ongoing expansion of basic health care facilities in emerging markets will support market growth.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for general radiography systems in the US, Europe (France, Germany, Italy, Spain, and the UK), Brazil, China, and Japan across a 10-year period.

Related Medtech Insights Reports

Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will grow modestly, driven by increasing complex CAD cases and the adoption of surgical technologies. Favorable clinical evidence, particularly in favor of CABG over PCI,…
Report
Biosurgical Agents | Medtech 360 | Market Insights | US | 2024
The biosurgical agent market in the US will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical…
Report
Diagnostic Imaging Systems – Market Insights – Japan
The diagnostic imaging system market in Japan will see slow growth through 2032. Manufacturers in this space are actively introducing technologically advanced products equipped with digital and AI…
Report
Interventional Cardiology Devices | Medtech 360 | Market Insights | Europe | 2023
The European IC device market has been able to recover from the COVID-19 pandemic and is seen as reverting to pre-pandemic sales. Steady uptake of several technologies has supported the IC device…
Report
Aortic Repair Devices | Medtech 360 | Market Analysis | Europe (Supplemental) | 2018
The European market for aortic repair devices will expand at a modest rate, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent…